| It is currently Wed May 22, 2013 7:45 pm |
|
All times are UTC - 8 hours [ DST ] |
|
Page 1 of 1 |
[ 1 post ] |
|
| Author | Message | |||||
|---|---|---|---|---|---|---|
| squiffy2 |
|
|||||
Joined: Wed Oct 14, 2009 3:00 pm Posts: 1686 |
|
|||||
| Top | |
|||||
|
Page 1 of 1 |
[ 1 post ] |
|
All times are UTC - 8 hours [ DST ] |
| Topics | Author | Replies | Views | Last post | |
|---|---|---|---|---|---|
| XenoPort to drop multiple sclerosis drug after trial failure | 0 | 71 | Mon May 20, 2013 6:10 am | ||
| Genmab announces results of Ofatumumab phase II study in MS | 0 | 761 | Mon Sep 13, 2010 2:27 am | ||
| A story about Glaxo and Avandia | 0 | 619 | Fri Mar 19, 2010 4:16 pm | ||
| Glaxo to concentrate on three neurological areas only | 1 | 788 | Sat Feb 06, 2010 5:11 pm | ||
| Bad Medicine : The Glaxo Case - 60 Minutes | 0 | 796 | Tue Jan 04, 2011 9:04 am | ||
Who is online |
Users browsing this forum: No registered users |
| You cannot post new topics in this forum You cannot reply to topics in this forum You cannot edit your posts in this forum You cannot delete your posts in this forum |